NeuroOne Medical Technologies (NASDAQ:NMTC – Get Free Report) and CVRx (NASDAQ:CVRX – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, institutional ownership, profitability and earnings.
Risk & Volatility
NeuroOne Medical Technologies has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500. Comparatively, CVRx has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500.
Profitability
This table compares NeuroOne Medical Technologies and CVRx’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| NeuroOne Medical Technologies | -71.50% | -128.12% | -86.34% |
| CVRx | -84.93% | -152.35% | -50.93% |
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| NeuroOne Medical Technologies | 1 | 1 | 3 | 0 | 2.40 |
| CVRx | 1 | 3 | 2 | 0 | 2.17 |
NeuroOne Medical Technologies presently has a consensus target price of $7.33, indicating a potential upside of 591.82%. CVRx has a consensus target price of $4.30, indicating a potential upside of 220.90%. Given NeuroOne Medical Technologies’ stronger consensus rating and higher probable upside, research analysts plainly believe NeuroOne Medical Technologies is more favorable than CVRx.
Valuation & Earnings
This table compares NeuroOne Medical Technologies and CVRx”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| NeuroOne Medical Technologies | $9.47 million | 1.02 | -$3.61 million | ($0.95) | -1.12 |
| CVRx | $56.65 million | 0.63 | -$53.31 million | ($1.98) | -0.68 |
NeuroOne Medical Technologies has higher earnings, but lower revenue than CVRx. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.
Institutional and Insider Ownership
16.1% of NeuroOne Medical Technologies shares are held by institutional investors. Comparatively, 75.3% of CVRx shares are held by institutional investors. 11.8% of NeuroOne Medical Technologies shares are held by insiders. Comparatively, 16.6% of CVRx shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
NeuroOne Medical Technologies beats CVRx on 8 of the 13 factors compared between the two stocks.
About NeuroOne Medical Technologies
NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.
About CVRx
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Receive News & Ratings for NeuroOne Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeuroOne Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
